Evidence map›Paper›PMID 34081833›Full record

ArticleMicrobial biotechnology2021

Endophytes isolated from Panax notoginseng converted ginsenosides.

Guangfei Wei, Zhongjian Chen, Bo Wang, Fugang Wei, Guozhuang Zhang, Yong Wang, Guangwei Zhu, Yuxin Zhou, Qinghe Zhao, Mingjun He and 2 more

Abstract read
In one paragraph

Article in Microbial biotechnology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Horticulture research · 2024
    Review
  10. Article
  11. Revealing Medicinal Constituents ofMolecules (Basel, Switzerland) · 2024
    Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Ginsenosides and Biotic Stress Responses of Ginseng.Plants (Basel, Switzerland) · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Guangfei Wei *Key Laboratory of Beijing for Identification and Safety Evaluation of Chinese Medicine, Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, No.16 Nanxiaojie, Dongzhimennei Ave, Beijing, 100700, China.
Zhongjian Chen *Institute of Sanqi Research, Wenshan University, Wenshan, 663000, China.
Bo Wang *Hubei Institute for Drug Control, Wuhan, 430012, China.
Fugang WeiWenshan Miaoxiang Notoginseng Technology, Co., Ltd., Wenshan, 663000, China.
Guozhuang ZhangKey Laboratory of Beijing for Identification and Safety Evaluation of Chinese Medicine, Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, No.16 Nanxiaojie, Dongzhimennei Ave, Beijing, 100700, China.
Yong WangInstitute of Sanqi Research, Wenshan University, Wenshan, 663000, China.
Guangwei ZhuKey Laboratory of Beijing for Identification and Safety Evaluation of Chinese Medicine, Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, No.16 Nanxiaojie, Dongzhimennei Ave, Beijing, 100700, China.
Yuxin ZhouKey Laboratory of Beijing for Identification and Safety Evaluation of Chinese Medicine, Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, No.16 Nanxiaojie, Dongzhimennei Ave, Beijing, 100700, China.
Qinghe ZhaoKey Laboratory of Beijing for Identification and Safety Evaluation of Chinese Medicine, Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, No.16 Nanxiaojie, Dongzhimennei Ave, Beijing, 100700, China.
Mingjun HeHainan Branch Institute of Medicinal Plant, Chinese Academy of Medical Sciences & Peking Union Medical College, Wanning, 571533, China.
Linlin DongKey Laboratory of Beijing for Identification and Safety Evaluation of Chinese Medicine, Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, No.16 Nanxiaojie, Dongzhimennei Ave, Beijing, 100700, China.ORCID 0000-0002-2054-8749
Shilin ChenKey Laboratory of Beijing for Identification and Safety Evaluation of Chinese Medicine, Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, No.16 Nanxiaojie, Dongzhimennei Ave, Beijing, 100700, China.

Funding

Beijing Nova Program Z181100006218020Fundamental Research Funds for the Central public welfare research institutes ZXKT17049Fundamental Research Funds for the Central public welfare research institutes ZZ13-AQ-049Major Science and Technology Projects of Yunnan Province 2018ZF011National Key R&D Plan 2017YFC1702500
6 · The paper itself

Abstract

Endophytes may participate in the conversion of metabolites within medicinal plants, influencing the efficacy of host. However, the distribution of endophytes within medicinal plants P. notoginseng and how it contributes to the conversion of saponins are not well understood. Here, we determined the distribution of saponins and endophytes within P. notoginseng compartments and further confirm the saponin conversion by endophytes. We found metabolites showed compartment specificity within P. notoginseng. Potential saponin biomarkers, such as Rb1, Rg1, Re, Rc and Rd, were obtained. Endophytic diversity, composition and co-occurrence networks also showed compartment specificity, and bacterial alpha diversity values were highest in root compartment, consistently decreased in the stem and leaf compartments, whereas those of fungi showed the opposite trend. Potential bacterial biomarkers, such as Rhizobium, Bacillus, Pseudomonas, Enterobacter, Klebsiella, Pantoea and fungal biomarkers Phoma, Epicoccum, Xylariales, were also obtained. Endophytes related to saponin contents were found by Spearman correlation analysis, and further verification experiments showed that Enterobacter chengduensis could convert ginsenoside Rg1 to F1 at a rate of 13.24%; Trichoderma koningii could convert ginsenoside Rb1 to Rd at a rate of 40.00% and to Rg3 at a rate of 32.31%; Penicillium chermesinum could convert ginsenoside Rb1 to Rd at a rate of 74.24%.

Indexed as

GinsenosidesPanax notoginsengEndophytesEnterobacterHypocrealesPenicilliumGinsenosides

Identifiers

PMID34081833
PMCPMC8313278

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.